What is Tirzepatide? The Breakthrough Dual Agonist for Weight Loss and Glycemic Control
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist medication approved for the treatment of type 2 diabetes and weight loss.
April 13, 2024
